Gelonghui, March 13 | The innovative drug sector in the A-share market rose in the afternoon, leading in the direction of AI pharmaceuticals. Hongbo Pharmaceutical rose more than 10%, while Chengdu Pioneer, Kain Technology, Zhixiang Jintai, Maiwei Biotech, and Alice followed suit. According to the news, recently, Insilicon Intelligence, one of the unicorns of AI pharmaceuticals in China, published a research paper in the “Nature-Biotech” magazine, revealing the entire process of the TNIK inhibitor developed by the company using artificial intelligence, from target discovery to phase II clinical development, and disclosed for the first time the pre-clinical and clinical trial data of this AI drug.
A股异动丨创新药板块午后拉升 AI制药方向领涨
A-share changes丨The innovative drug sector rallied in the afternoon, leading the way in AI pharmaceuticals
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.